nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR3—skull—otosclerosis	0.124	0.199	CbGeAlD
Ponatinib—FGFR3—cartilage tissue—otosclerosis	0.106	0.17	CbGeAlD
Ponatinib—FGFR2—skull—otosclerosis	0.0814	0.13	CbGeAlD
Ponatinib—FGFR4—connective tissue—otosclerosis	0.0387	0.062	CbGeAlD
Ponatinib—PDGFRA—Osteoblast Signaling—COL1A1—otosclerosis	0.0344	0.0915	CbGpPWpGaD
Ponatinib—FGFR4—Syndecan-1-mediated signaling events—COL1A1—otosclerosis	0.0327	0.087	CbGpPWpGaD
Ponatinib—ABL1—Lissencephaly gene (LIS1) in neuronal migration and development—RELN—otosclerosis	0.0297	0.0791	CbGpPWpGaD
Ponatinib—LYN—connective tissue—otosclerosis	0.0265	0.0425	CbGeAlD
Ponatinib—FGFR3—connective tissue—otosclerosis	0.0264	0.0423	CbGeAlD
Ponatinib—FGFR3—Syndecan-1-mediated signaling events—COL1A1—otosclerosis	0.0242	0.0644	CbGpPWpGaD
Ponatinib—FLT3—connective tissue—otosclerosis	0.0227	0.0363	CbGeAlD
Ponatinib—KDR—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.0191	0.0508	CbGpPWpGaD
Ponatinib—RET—connective tissue—otosclerosis	0.0182	0.0291	CbGeAlD
Ponatinib—FGFR2—connective tissue—otosclerosis	0.0173	0.0277	CbGeAlD
Ponatinib—TEK—connective tissue—otosclerosis	0.0166	0.0265	CbGeAlD
Ponatinib—BCR—tendon—otosclerosis	0.0157	0.0251	CbGeAlD
Ponatinib—PDGFRA—connective tissue—otosclerosis	0.015	0.024	CbGeAlD
Ponatinib—SRC—connective tissue—otosclerosis	0.0147	0.0236	CbGeAlD
Ponatinib—KDR—Integrins in angiogenesis—COL1A1—otosclerosis	0.0141	0.0374	CbGpPWpGaD
Ponatinib—FGFR1—tendon—otosclerosis	0.014	0.0224	CbGeAlD
Ponatinib—RET—Dopaminergic Neurogenesis—TGFB1—otosclerosis	0.0135	0.036	CbGpPWpGaD
Ponatinib—KDR—connective tissue—otosclerosis	0.0135	0.0217	CbGeAlD
Ponatinib—LCK—Inflammatory Response Pathway—COL1A1—otosclerosis	0.0135	0.036	CbGpPWpGaD
Ponatinib—SRC—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0126	0.0336	CbGpPWpGaD
Ponatinib—RET—tendon—otosclerosis	0.0125	0.02	CbGeAlD
Ponatinib—KIT—connective tissue—otosclerosis	0.012	0.0192	CbGeAlD
Ponatinib—TEK—tendon—otosclerosis	0.0114	0.0182	CbGeAlD
Ponatinib—KDR—Focal Adhesion—RELN—otosclerosis	0.0108	0.0288	CbGpPWpGaD
Ponatinib—ABL1—connective tissue—otosclerosis	0.0104	0.0167	CbGeAlD
Ponatinib—PDGFRA—tendon—otosclerosis	0.0103	0.0165	CbGeAlD
Ponatinib—FGFR4—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.0097	0.0258	CbGpPWpGaD
Ponatinib—KDR—tendon—otosclerosis	0.0093	0.0149	CbGeAlD
Ponatinib—FGFR4—Syndecan-1-mediated signaling events—TGFB1—otosclerosis	0.00929	0.0247	CbGpPWpGaD
Ponatinib—PDGFRA—Focal Adhesion—RELN—otosclerosis	0.00794	0.0211	CbGpPWpGaD
Ponatinib—ABL1—tendon—otosclerosis	0.00718	0.0115	CbGeAlD
Ponatinib—FGFR3—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00717	0.0191	CbGpPWpGaD
Ponatinib—FGFR3—Syndecan-1-mediated signaling events—TGFB1—otosclerosis	0.00687	0.0183	CbGpPWpGaD
Ponatinib—SRC—Integrins in angiogenesis—COL1A1—otosclerosis	0.00661	0.0176	CbGpPWpGaD
Ponatinib—FGFR1—Glypican 1 network—TGFB1—otosclerosis	0.00597	0.0159	CbGpPWpGaD
Ponatinib—KDR—Focal Adhesion—COL1A1—otosclerosis	0.00582	0.0155	CbGpPWpGaD
Ponatinib—LYN—Glypican 1 network—TGFB1—otosclerosis	0.00525	0.014	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—RELN—otosclerosis	0.00508	0.0135	CbGpPWpGaD
Ponatinib—KDR—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00459	0.0122	CbGpPWpGaD
Ponatinib—FGFR3—Endochondral Ossification—TGFB1—otosclerosis	0.00453	0.012	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—COL1A1—otosclerosis	0.00447	0.0119	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00439	0.0117	CbGpPWpGaD
Ponatinib—LCK—Glypican 1 network—TGFB1—otosclerosis	0.0043	0.0114	CbGpPWpGaD
Ponatinib—PDGFRA—Focal Adhesion—COL1A1—otosclerosis	0.00427	0.0114	CbGpPWpGaD
Ponatinib—KIT—Differentiation Pathway—TGFB1—otosclerosis	0.00385	0.0102	CbGpPWpGaD
Ponatinib—SRC—Glypican 1 network—TGFB1—otosclerosis	0.00381	0.0101	CbGpPWpGaD
Ponatinib—KIT—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00356	0.00946	CbGpPWpGaD
Ponatinib—FGFR2—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00351	0.00935	CbGpPWpGaD
Ponatinib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00337	0.00895	CbGpPWpGaD
Ponatinib—LYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00316	0.00841	CbGpPWpGaD
Ponatinib—SRC—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00294	0.00781	CbGpPWpGaD
Ponatinib—FGFR1—Endochondral Ossification—TGFB1—otosclerosis	0.0029	0.00772	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—COL1A1—otosclerosis	0.00273	0.00727	CbGpPWpGaD
Ponatinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00259	0.0069	CbGpPWpGaD
Ponatinib—FGFR2—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.0025	0.00666	CbGpPWpGaD
Ponatinib—SRC—Interleukin-11 Signaling Pathway—TGFB1—otosclerosis	0.0025	0.00665	CbGpPWpGaD
Ponatinib—PDGFRA—Allograft Rejection—TGFB1—otosclerosis	0.00245	0.00651	CbGpPWpGaD
Ponatinib—ABL1—Regulation of Telomerase—TGFB1—otosclerosis	0.00242	0.00644	CbGpPWpGaD
Ponatinib—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00241	0.00642	CbGpPWpGaD
Ponatinib—SRC—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00229	0.0061	CbGpPWpGaD
Ponatinib—ABL1—Cell Cycle—TGFB1—otosclerosis	0.00175	0.00466	CbGpPWpGaD
Ponatinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.00166	0.00441	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00134	0.00357	CbGpPWpGaD
Ponatinib—KDR—Extracellular matrix organization—TGFB1—otosclerosis	0.00127	0.00338	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—TGFB1—otosclerosis	0.00126	0.00335	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00125	0.00332	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00121	0.00322	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00121	0.00321	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.00106	0.00282	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00104	0.00276	CbGpPWpGaD
Ponatinib—LYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000947	0.00252	CbGpPWpGaD
Ponatinib—ABCB1—Allograft Rejection—TGFB1—otosclerosis	0.000926	0.00246	CbGpPWpGaD
Ponatinib—BCR—Disease—TGFB1—otosclerosis	0.000804	0.00214	CbGpPWpGaD
Ponatinib—LCK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000776	0.00207	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000773	0.00205	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—TGFB1—otosclerosis	0.000769	0.00205	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000687	0.00183	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFB1—otosclerosis	0.000567	0.00151	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TGFB1—otosclerosis	0.000566	0.0015	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFB1—otosclerosis	0.000563	0.0015	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TGFB1—otosclerosis	0.000498	0.00132	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TGFB1—otosclerosis	0.000495	0.00132	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TGFB1—otosclerosis	0.000488	0.0013	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TGFB1—otosclerosis	0.000486	0.00129	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000457	0.00122	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFB1—otosclerosis	0.000419	0.00111	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TGFB1—otosclerosis	0.0004	0.00106	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFB1—otosclerosis	0.000397	0.00106	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—otosclerosis	0.000361	0.000961	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—otosclerosis	0.000354	0.000942	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—otosclerosis	0.000294	0.000781	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—otosclerosis	0.000288	0.000767	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—otosclerosis	0.000283	0.000753	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—otosclerosis	0.000269	0.000715	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—otosclerosis	0.000268	0.000713	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—otosclerosis	0.000256	0.00068	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—otosclerosis	0.000202	0.000537	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—otosclerosis	0.000198	0.000527	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—otosclerosis	0.000194	0.000515	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—otosclerosis	0.000188	0.000501	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—otosclerosis	0.000188	0.000499	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—otosclerosis	0.000172	0.000456	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—otosclerosis	0.000166	0.00044	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—otosclerosis	0.000136	0.000361	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—otosclerosis	0.00012	0.00032	CbGpPWpGaD
